FRIDAY, April 12, 2024 (HealthDay News) -- Patients using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) undergoing endoscopic procedures have an increased risk for aspiration pneumonia, according to a study published online March 27 in Gastroenterology
In its first registrational Phase 3 obesity trial (TRIUMPH-1), average weight loss reached 28.3% at 80 weeks and up to 30.3% at 104 weeks in a select extension cohort
Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
Additionally, the platform's ability to analyze vast amounts of data allows it to identify trends and provide insights that can lead to better health outcomes, empowering patients to take an active role in their healthcare decisions
Basically, I was giving myself the same dose because the ten units at the higher concentration are equivalent to 20 units at the lower concentration
Aside from products that claim to influence GLP-1 levels, another class of GLP-1 supplements has emerged that is marketed toward users of GLP-1 drugs (or former users)